We had a robust volume today, 3.94 million, which might be a good sign of the forthcoming twist. As someone on this forum said, biotech stock market in Australia is a brutal place where investors who keep faith have to face cruel reality in many cases. Believers may have to go to hell before they get to heaven. If winter comes, can spring be far behind?
IMO, now is good entry point for investors who really understand the true value of PAB to take over cheap shares from weak hands who have chosen to suffer a great realised loss. I am ready for 0.009 and below. But as always, DYOR.
What's the root cause of PAB's poor SP performance?, page-20
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1284114 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1116001 | 3 |
View Market Depth
| Last trade - 16.12pm 29/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable